Repository logo
 

A Systematic Review of the Biological Effects of Cordycepin.

Published version
Peer-reviewed

Change log

Authors

Radhi, Masar 
Ashraf, Sadaf 
Lawrence, Steven 
Tranholm, Asta Arendt 
Wellham, Peter Arthur David 

Abstract

We conducted a systematic review of the literature on the effects of cordycepin on cell survival and proliferation, inflammation, signal transduction and animal models. A total of 1204 publications on cordycepin were found by the cut-off date of 1 February 2021. After application of the exclusion criteria, 791 papers remained. These were read and data on the chosen subjects were extracted. We found 192 papers on the effects of cordycepin on cell survival and proliferation and calculated a median inhibitory concentration (IC50) of 135 µM. Cordycepin consistently repressed cell migration (26 papers) and cellular inflammation (53 papers). Evaluation of 76 papers on signal transduction indicated consistently reduced PI3K/mTOR/AKT and ERK signalling and activation of AMPK. In contrast, the effects of cordycepin on the p38 and Jun kinases were variable, as were the effects on cell cycle arrest (53 papers), suggesting these are cell-specific responses. The examination of 150 animal studies indicated that purified cordycepin has many potential therapeutic effects, including the reduction of tumour growth (37 papers), repression of pain and inflammation (9 papers), protecting brain function (11 papers), improvement of respiratory and cardiac conditions (8 and 19 papers) and amelioration of metabolic disorders (8 papers). Nearly all these data are consistent with cordycepin mediating its therapeutic effects through activating AMPK, inhibiting PI3K/mTOR/AKT and repressing the inflammatory response. We conclude that cordycepin has excellent potential as a lead for drug development, especially for age-related diseases. In addition, we discuss the remaining issues around the mechanism of action, toxicity and biodistribution of cordycepin.

Description

Keywords

AKT, AMPK, ERK, cell viability, cordycepin, inflammation, mTOR, natural product, review, signal transduction, Animals, Antineoplastic Agents, Brain Diseases, Deoxyadenosines, Humans, Inflammation, Metabolic Diseases, Neoplasms, Signal Transduction

Journal Title

Molecules

Conference Name

Journal ISSN

1420-3049
1420-3049

Volume Title

26

Publisher

MDPI AG
Sponsorship
Versus Arthritis (21586)
Biotechnology and Biological Sciences Research Council (BB/M008770/1)